Differential stromal and epithelial localization of cyclooxygenase-2 (COX-2) during colorectal tumorigenesis

被引:0
|
作者
Amoletti, JP
Upson, J
Babb, JS
Bellacosa, A
Watson, JC
机构
[1] Fox Chase Canc Ctr, Dept Human Genet, Philadelphia, PA 19111 USA
[2] Univ Alabama Birmingham, Dept Surg, Sect Surg Oncol, Birmingham, AL 35294 USA
[3] Fox Chase Canc Ctr, Dept Biostat, Philadelphia, PA 19111 USA
[4] Fox Chase Canc Ctr, Dept Surg Oncol, Philadelphia, PA 19111 USA
来源
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | 2005年 / 24卷 / 02期
关键词
COX-2; protein; mRNA; colorectal cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of the following study is to describe the localization of COX-2 protein and COX-2 mRNA during human colorectal tumorigenesis and to identify potential cellular targets for COX-2 inhibition in chemopreventive strategies. Immunohistochemistry with digital image analysis was used to determine COX-2 protein expression in histologic sections containing synchronous normal colorectal mucosa, adenomas and carcinomas, from 17 previously untreated patients. Epithelial and stromal COX-2 mRNA expression was analyzed by reverse transcription-polymerase chain reaction (RT-PCR), on laser-capture microdissected samples from the same histologies. The stromal compartment in normal colorectal mucosa and adenomas showed higher levels of COX-2 protein expression compared to colorectal carcinomas (p < .0001). Conversely, epithelial COX-2 protein was significantly increased only after development of the invasive phenotype (p < .0001). RT-PCR demonstrated higher stromal COX-2 mRNA expression compared to that within the epithelium for colorectal adenomas and carcinomas. In conclusion, stromal COX-2 may be the target for chemopreventive agents in the early stages of colorectal carcinogenesis.
引用
收藏
页码:279 / 287
页数:9
相关论文
共 50 条
  • [21] COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis
    Zheng, Yu
    Comaills, Valentine
    Burr, Risa
    Boulay, Gaylor
    Miyamoto, David T.
    Wittner, Ben S.
    Emmons, Erin
    Sil, Srinjoy
    Koulopoulos, Michael W.
    Broderick, Katherine T.
    Tai, Eric
    Rengarajan, Shruthi
    Kulkarni, Anupriya S.
    Shioda, Toshi
    Wu, Chin-Lee
    Ramaswamy, Sridhar
    Ting, David T.
    Toner, Mehmet
    Rivera, Miguel N.
    Maheswaran, Shyamala
    Haber, Daniel A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (12) : 5223 - 5232
  • [22] Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade
    Lin, CD
    Kenyon, L
    Hyslop, T
    Hammond, E
    Andrews, DW
    Curran, WJ
    Dicker, AP
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : S98 - S102
  • [23] Metal Enhanced Electrochemical Cyclooxygenase-2 (COX-2) Sensor for Biological Applications
    Noah, Naumih M.
    Marcells, Omole
    Almalleti, Anas
    Lim, Jae
    Sadik, Omowunmi A.
    ELECTROANALYSIS, 2011, 23 (10) : 2392 - 2399
  • [24] Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients
    Vogt, Liffert
    de Zeeuw, Dick
    Woittiez, Arend Jan J.
    Navis, Gerjan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (04) : 1182 - 1189
  • [25] Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events
    Mukherjee, D
    BIOCHEMICAL PHARMACOLOGY, 2002, 63 (05) : 817 - 821
  • [26] Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDH
    Wang, Jiping
    Cho, Nancy L.
    Zauber, Ann G.
    Hsu, Meier
    Dawson, Dawn
    Srivastava, Amitabh
    Mitchell-Richards, Kisha A.
    Markowitz, Sanford D.
    Bertagnolli, Monica M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 728 - 736
  • [27] Effect of cyclooxygenase-2 (COX-2) inhibitors on prostate cancer cell proliferation
    Srinath, P
    Rao, PNP
    Knaus, EE
    Suresh, MR
    ANTICANCER RESEARCH, 2003, 23 (5A) : 3923 - 3928
  • [28] Comparative molecular field analysis of selective cyclooxygenase-2 (COX-2) inhibitors
    Marot, C
    Chavatte, P
    Lesieur, D
    QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 2000, 19 (02): : 127 - 134
  • [29] Different expression of cyclooxygenase-2 (COX-2) in selected nonmelanocytic human cutaneous lesions
    Kuzbicki, Lukasz
    Lange, Dariusz
    Stanek-Widera, Agata
    Chwirot, Barbara W.
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2011, 49 (03) : 381 - 388
  • [30] Immunohistochemical expression of cyclooxygenase-2 (COX-2) is not associated with tumor grade in feline meningiomas
    Samarani, F.
    de la Fuente, C.
    Parodi, A.
    Mandara, M. T.
    Pumarola, M.
    Anor, S.
    VETERINARY JOURNAL, 2018, 241 : 20 - 23